YOU can SAVE the LIFE of a RELATIVE, a FRIEND, a PARTNER, or a STRANGER.
PLEASE help spread the word, BOOST !!!
#Covid19 #CovidIsAirborne #WearAMask #CovidIsNotOver
| Linkedin: | linkedin.com/in/adolfor20 |
| Twitter: | twitter.com/adolfor20 |
| Mastodon: | [email protected] |
| Location: | Buenos Aires, Argentina |
She conveys her message with a clarity few possess.
RT: @pot8um
Still true in 2025!
Covid doesn’t have a cure.
Neither does long covid.
The vax alone isn’t enough to protect or prevent.
Masks work. They work better when worn in community. One-way masking can only do so much. Disabled people are bearing the brunt of the world’s indifference.
RT: @iseeuliars
"...If you once masked “to protect the vulnerable” and then you stopped at some point, you prioritized personal comfort and social convenience over community care. And quite honestly, over other peoples’ lives.
What’s worse is you refuse to admit it. Even to yourselves..."
RT: @thrivingplanet.bsky.social
In Sep '23 this John Snow Project* article drew together the science on Covid viral persistence, advancing a hypothesis with implications so great most prefer to pretend it's not happening*.
https://johnsnowproject.org/insights/a-new-disease-paradigm/
Doctors Warn COVID-19 Could Be a Hidden Trigger for Heart Attacks Long After Recovery
Coffee for Covid.
This study verified moderate coffee consumption, including decaffeination, can provide a new guideline for the prevention of SARS-CoV-2. Based on the results, we also suggest a coffee-drinking plan for people to prevent infection in the post-COVID-19 era.
Threads: @braininflammationcollab
“The SARS-CoV-2 spike protein was recently found to localize in an unusual place outside the brain.
This localization pattern might explain the neuroinflammatory symptoms experienced during:
- SARS-CoV-2 infection
- Long COVID..🧵”
https://www.cell.com/cms/10.1016/j.chom.2024.11.007/attachment/4209ecf1-b91e-432d-9707-b69faa6dd986/mmc4.mp4
“Researchers from Ludwig-Maximilians-University Munich, Munich, Germany found that the SARS-CoV-2 spike protein localizes to the skull's bone marrow.
To understand why this discovery is important in the context of Long COVID we must first learn about the following:
- the meninges
- immune cells in the meninges
Read the scientific publication here:”
https://buff.ly/3DNfPGL
“\ Background - Skull Meninges Connections (SMCs):
The brain is wrapped in a 3-layer membrane called the meninges.
This protective membrane contains resident immune cells that do not come from circulation.
Instead, they traffic through specialized channels from the skull's bone marrow (to the meninges) (1).”
“But why is it important for immune cells in the meninges to come from the skull and not the blood?”
“Surprisingly, immune cells from the skull’s marrow behave differently than those from the blood. Specifically, scientists found they are (1):
- less likely to trigger autoimmunity
- less inflammatory in nature
They can also rapidly penetrate the brain following injury or inflammation (1).
Now back to the new Long COVID paper…”
“\ Results:
As we mentioned above, the spike protein was found in the skull’s bone marrow and meninges in mice.
This was associated with:
- exacerbated outcomes of stroke and traumatic brain injury
- changes in the skull-meninge physiology
- anxiety-like behavior
They also found spike protein in the skull of humans previously infected with SARS-CoV-2 but later died from non-COVID-related complications.”
“\ Results:
Further results found that injecting the spike protein directly into the skull’s bone marrow, which is outside the brain (in 🐁 ), caused pathology inside the brain such as:
- neuronal stress
- neuroinflammation”
“\ Conclusion:
This data suggests that the spike protein’s ability to accumulate in the skull’s bone marrow might be responsible for neuroinflammation (brain fog) experienced following a SARS-CoV-2 infection and in those with Long COVID.
This work also might also, “suggest a mechanism for the virus’s entry into the central nervous system “ (i.e. the skull’s bone marrow-meninge axis).”
“\ Therapeutic Implications:
The skull’s bone marrow is not behind the blood-brain barrier.
Thus, if a viable anti-neuroinflammatory target is discovered in the skull marrow, it wouldn’t need to meet the burdensome criteria of crossing the BBB.
However, more work is required to identify this putative drug candidate(s).”
“We at the Brain Inflammation Collaborative are on a mission to help scientists understand how complex neuroimmune axis conditions such as Long COVID impact our brain health and mental health.
Join our mission by sharing this content and giving it a like!
Literature Cited:
1. Cugurra, A., Mamuladze, T. et al. Science. Jul 23, 2021. PMID: 34083447”
ALCOHOL LINKED TO CANCER
The types of cancer with the most cases linked to alcohol use were cancers of the esophagus and liver and, in women, breast cancer, the researchers reported July 13 in The Lancet Oncology.
Alcohol can raise the risk of cancer in many ways.
The processes that the body uses to break down alcohol produce a compound called acetaldehyde, a toxin that several organizations have classified as a probable cause of cancer in people.
The breakdown of alcohol can also produce reactive oxygen species, also known as free radicals. These molecules can damage DNA, and the gene changes that result can lead to a cell turning cancerous.
Alcohol can also have more subtle cancer-promoting effects, including impairing the body’s ability to metabolize and absorb a variety of nutrients it needs to prevent cancer.
It can also increase blood levels of estrogen, a sex hormone linked to breast cancer, and make the carcinogens found in tobacco smoke easier for the body to absorb.
https://www.cancer.gov/news-events/cancer-currents-blog/2021/cancer-alcohol-global-burden
Nearly 750,000 cases of cancer diagnosed worldwide in 2020, or 4%, can be attributed to alcohol consumption, according to a new World Health Organization (WHO) study. While heavy drinking accounted for the most cases, light and moderate drinking accounted for more than 100,000 of those cases.
Adolfo Rineckki
